Quest Diagnostics marks two years of COVID-19 testing
In March 2022, Quest Diagnostics marked two years since its first COVID-19 test. Since the company introduced its first COVID-19 tests in March 2020, it has performed about 65.0 million COVID-19 molecular diagnostic tests. While Quest began COVID-19 testing with a single laboratory in California to two dozen labs throughout the US. In the two years of COVID-19 testing, Quest has received 20 emergency use authorizations from the FDA for COVID-19 innovations, developed advanced testing capabilities and collaborated with the CDC and other entities to identify COVID-19 variants.
COVID|ESGIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.